castle trial eligibility
The Next CASTLE Trial in Chronic Disease Management
The CASTLE trial is a cutting-edge CAR-T study for chronic autoimmune disease, and you qualify only if you meet strict immunologic and treatment-failure criteria, complete the digital consent process, and satisfy organ-function thresholds. In 2024, the CASTLE basket trial reported a 68% complete remission rate among heavily pre-treated rheumatology patients,